I Predicted That Nvidia Would Beat the S&P 500 for the 3rd Consecutive Year in 2025. Here's Why the Streak Can Continue in 2026.

Nvidia has reported a surge in booked orders — previously guided $500 billion in Blackwell and Rubin orders and said at CES that orders have since exceeded that level — and announced six new Rubin chips now in full production with deliveries beginning in H2 calendar 2026. Analysts have materially raised estimates, with consensus EPS now $4.69 for fiscal 2026 and $7.60 for fiscal 2027 (up from $4.29 and $5.76 six months prior), while Nvidia touts Rubin efficiency gains of up to a 90% reduction in inference token cost and a 75% cut in GPUs needed for training. The combination of strong demand, product-driven margin expansion and a ~39x forward P/E supports a constructive investment case, though the piece flags downside risk if hyperscalers eventually pull back on capital expenditures.

Analysis

Market structure: Nvidia (NVDA) is the clear near-term winner — Rubin’s claimed 75% GPU count and up to 90% inference token cost improvements give Nvidia pricing power and justify premium ASPs, benefiting upstream suppliers (TSMC, ASML, LRCX) and rack/network vendors while squeezing GPU-focused rivals (AMD, INTC) and small AI-chip entrants. The $500B+ booked orders signal demand >> supply for next 12–24 months, creating sustained order visibility and likely extended fab allocations; expect elevated implied volatility in NVDA options and widening credit spreads for leveraged smaller chipmakers if revenue misses emerge.

Risk assessment: Tail risks include a hyperscaler capex pause (a 20–30% YoY cut would create a high-impact revenue shock), supply-chain shocks at TSMC or yield setbacks, and export/regulatory actions that could block key markets; these are low-probability but material. Short-term (days–months) risk is event-driven volatility around production ramp commentary and quarterly guides; long-term (quarters–years) risk is customer ROI discipline forcing slower spend conversion of booked orders.

Trade implications: Favor asymmetric exposure — size directional long exposure to NVDA modestly and use structured options to cap downside. Implement relative-value trades (long NVDA/short AMD) to capture share-shift while hedging market beta. Rotate portfolio into semicap/equipment and networking names for 6–18 months while trimming cyclical legacy CPU/PC suppliers.

Key Decisions for Investors

• Establish a 2–3% net long position in NVDA now; scale to 5% if NVDA pulls back 10–15% intraday or within 8 weeks; use a hard stop-loss at -12% from entry and target a 12-month upside of +25–40% if Rubin revenue ramps as guided.
• Buy a 9–12 month call spread on NVDA: buy ATM calls and sell 25–30% OTM calls (size = ~1% portfolio) to capture upside from Rubin adoption while financing premium; close if NVDA rises >35% or if quarterly guide reduces expected Rubin shipment cadence.
• Execute a pair trade: go long NVDA (1.0x notional) and short AMD (0.7–1.0x notional) to express expected margin and share gains from Rubin; rebalance or close if the pair diverges more than 15% in 60 days or if AMD announces a competing win with demonstrable cost parity.
• Hedge tail risk: if NVDA position >3% of portfolio, buy 6-month puts 20% OTM sized to cover ~50% of position; additionally, set market alerts to reduce NVDA exposure by 50% within 30 days if aggregate hyperscaler capex guidance (Amazon/MSFT/Google) is cut >10% QoQ.